Home › Research › Brain scans and imaging
Meta-analysis of glucose metabolism across Alzheimer's, Parkinson's and ALS reveals distinct patterns of cortical hypometabolism versus subcortical hypermetabolism with disease-specific spatial signatures
Raikes, A. C.; Garza, M.; Tirambulo, C. V. G.; Murrell, A. N.; Brinton, R. D.. medRxiv (preprint), 2026-08-31
Topic: Brain proteins, microglia and lab models
Plain-language summary
The purpose of this meta-analysis was to determine the common signature of dysregulated brain glucose metabolism in late-onset age-associated neurodegenerative diseases (A2NDs), including Alzheimer disease, Parkinson disease, and amyotrophic lateral sclerosis. FDG-PET studies published through July 2025 were identified from MEDLINE, Embase, PsycINFO, Scopus, and Cochrane databases. Studies comparing adults with late-onset neurodegenerative disease to healthy controls and reporting whole-brain coordinate findings were included. Activation likelihood estimation meta-analyses were conducted using extracted coordinates of hypo- and hypermetabolism. A total of 130 studies were included, comprising 5,298 individuals with A2ND and 3,499 controls. Meta-analyses revealed dysregulated glucose metabolism as a unifying feature across A2NDs and included both hypo- and hypermetabolic patterns. However, the spatial distribution of metabolic abnormalities differed across diseases, with each disease demonstrating distinct neuroanatomical patterns associated with disease-relevant functional systems. While hypometabolism primarily in the cortex remains a primary focus in neurodegenerative disease research due to functional relevance, hypermetabolism was also consistently identified across all three diseases, predominantly in subcortical, limbic, and cerebellar structures. This dissociation, with hypermetabolic regions localized to structures with known functional connectivity to affected cortical networks, suggests compensatory upregulation as a plausible interpretation, though alternative mechanisms, including neuroinflammation, cannot be excluded.
What this study adds
Evidence grade: High
This is a pooled review of 5,298 participants. This meta-analysis found that altered brain glucose metabolism is a shared feature across Alzheimer's, Parkinson's and ALS, but each disease shows its own distinct spatial pattern of metabolic change. It does not test any treatment, cure or prevention, so it offers no direct implications for those goals.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Raikes, A. C., Garza, M., Tirambulo, C. V. G., Murrell, A. N., & Brinton, R. D. (2026). Meta-analysis of glucose metabolism across Alzheimer's, Parkinson's and ALS reveals distinct patterns of cortical hypometabolism versus subcortical hypermetabolism with disease-specific spatial signatures. medRxiv (preprint). https://doi.org/10.64898/2026.04.07.26350339
Vancouver
Raikes AC, Garza M, Tirambulo CVG, Murrell AN, Brinton RD. Meta-analysis of glucose metabolism across Alzheimer's, Parkinson's and ALS reveals distinct patterns of cortical hypometabolism versus subcortical hypermetabolism with disease-specific spatial signatures. medRxiv (preprint). 2026. doi:10.64898/2026.04.07.26350339.
BibTeX
@article{raikes2026-16df6f75,
author = {Raikes, A. C. and Garza, M. and Tirambulo, C. V. G. and Murrell, A. N. and Brinton, R. D.},
title = {{Meta-analysis of glucose metabolism across Alzheimer's, Parkinson's and ALS reveals distinct patterns of cortical hypometabolism versus subcortical hypermetabolism with disease-specific spatial signatures}},
journal = {medRxiv (preprint)},
year = {2026},
doi = {10.64898/2026.04.07.26350339},
url = {https://doi.org/10.64898/2026.04.07.26350339}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Meta-analyses revealed dysregulated glucose metabolism as a unifying feature across A2NDs and included both hypo- and hypermetabolic patterns.
- However, the spatial distribution of metabolic abnormalities differed across diseases, with each disease demonstrating distinct neuroanatomical patterns associated with disease-relevant functional systems.
Why it matters
This meta-analysis found that altered brain glucose metabolism is a shared feature across Alzheimer's, Parkinson's and ALS, but each disease shows its own distinct spatial pattern of metabolic change. It does not test any treatment, cure or prevention, so it offers no direct implications for those goals.
New to this subject? Start with our plain-English guide: Brain scans & tests →
Study details
- Study designmeta-analysis
- Participants5,298
- Evidence strengthHigh
How this study scored 16/100
Preprint — not yet peer-reviewed. It scored 45 on the same rubric, but non-peer-reviewed sources are capped at 16, so it shows as 16. Scored zero for effect reported because the record does not state it. We have no data on impact for its field and year, so that was left out: it earned 42 of the 94 points we could judge it on, which is 45 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 2 / 10 | Tier 4 — not a peer-reviewed journal (medRxiv (preprint)) |
| Journal's citation record | 0 / 4 | Not a journal article, so the journal's record does not count |
| Study design | 12 / 12 | A meta-analysis pooling many studies |
| Strength of evidence | 5 / 5 | Rated “high” in our summary |
| Peer-review validation | 4 / 10 | Preprint — not yet peer-reviewed. Hosted on a preprint server. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 3 / 4 | 5,298 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | A review of other studies — randomization is not credited here |
| Times cited | 1 / 7 | Cited 1 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.5 citations a year over 2 year(s) since 2026 |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Roberta Dı́az Brinton: h-index 88 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | University of Arizona: institution h-index 1,336 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 2 / 2 | Free to read |
| Points | 42 / 94 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 42 of the 94 points we could judge it on is 45 out of 100. |
| Total | 45 / 100 | Capped to 16 because this is not a peer-reviewed article. |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Brain scans and imaging from nearby years
Also tagged “precursor”
1,337 studies in the library carry the topic tag “precursor”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,337 tagged studies.